Lorraine Spector

Array ( [id] => 3660299 [patent_doc_number] => 05627267 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Cytokine designated elk ligand' [patent_app_type] => 1 [patent_app_number] => 8/458077 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15745 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627267.pdf [firstpage_image] =>[orig_patent_app_number] => 458077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286722 [patent_doc_number] => 06632424 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Human FLTS3 ligand' [patent_app_type] => B1 [patent_app_number] => 08/444626 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19438 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632424.pdf [firstpage_image] =>[orig_patent_app_number] => 08444626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421611 [patent_doc_number] => 08278099 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-10-02 [patent_title] => 'Monoclonal antibody to human thrombopoietin' [patent_app_type] => utility [patent_app_number] => 08/433767 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 102 [patent_no_of_words] => 60353 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 08433767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419167 [patent_doc_number] => 06225080 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Mu-subtype opioid receptor' [patent_app_type] => 1 [patent_app_number] => 8/430286 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 32 [patent_no_of_words] => 10026 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225080.pdf [firstpage_image] =>[orig_patent_app_number] => 430286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713111 [patent_doc_number] => 08399250 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-03-19 [patent_title] => 'Anti-mpl ligand (thromobpoietin) antibodies' [patent_app_type] => utility [patent_app_number] => 08/430035 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33397 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 08430035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8176241 [patent_doc_number] => 08178107 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-05-15 [patent_title] => 'Method of treatment of thrombocytopenia or risk thereof using MPL ligand (thrombopoietin), variants, and fragments thereof' [patent_app_type] => utility [patent_app_number] => 08/425020 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 22 [patent_no_of_words] => 45690 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178107.pdf [firstpage_image] =>[orig_patent_app_number] => 08425020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214629 [patent_doc_number] => 08193323 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-06-05 [patent_title] => 'mpl ligand (thrombopoietin), active fragments thereof, and fusion proteins and compositions comprising mpl ligand and other cytokines' [patent_app_type] => utility [patent_app_number] => 08/423194 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 32 [patent_no_of_words] => 45677 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193323.pdf [firstpage_image] =>[orig_patent_app_number] => 08423194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855162 [patent_doc_number] => 05792460 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Modified glycoprotein hormones having a CTP at the amino terminus' [patent_app_type] => 1 [patent_app_number] => 8/419519 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8432 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792460.pdf [firstpage_image] =>[orig_patent_app_number] => 419519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3842719 [patent_doc_number] => 05766581 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Method for treating mammals with monopegylated proteins that stimulates megakaryocyte growth and differentiation' [patent_app_type] => 1 [patent_app_number] => 8/413803 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 30234 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766581.pdf [firstpage_image] =>[orig_patent_app_number] => 413803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588346 [patent_doc_number] => 05585270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Polynucleotides encoding connective tissue growth factor' [patent_app_type] => 1 [patent_app_number] => 8/386680 [patent_app_country] => US [patent_app_date] => 1995-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7891 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585270.pdf [firstpage_image] =>[orig_patent_app_number] => 386680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763877 [patent_doc_number] => 05844095 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'CTLA4 Ig fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/375390 [patent_app_country] => US [patent_app_date] => 1995-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 43 [patent_no_of_words] => 26022 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/844/05844095.pdf [firstpage_image] =>[orig_patent_app_number] => 375390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727456 [patent_doc_number] => 05652123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms' [patent_app_type] => 1 [patent_app_number] => 8/371121 [patent_app_country] => US [patent_app_date] => 1995-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 9 [patent_no_of_words] => 25244 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652123.pdf [firstpage_image] =>[orig_patent_app_number] => 371121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3471829 [patent_doc_number] => 05476782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'DNA encoding a human 5-HT.sub.1E receptor and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/370542 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18362 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476782.pdf [firstpage_image] =>[orig_patent_app_number] => 370542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081055 [patent_doc_number] => 08147844 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-04-03 [patent_title] => 'Mpl ligand (thrombopoietin), nucleic acids encoding such, and methods of treatment using mpl ligand' [patent_app_type] => utility [patent_app_number] => 08/374540 [patent_app_country] => US [patent_app_date] => 1994-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 95 [patent_no_of_words] => 60356 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/147/08147844.pdf [firstpage_image] =>[orig_patent_app_number] => 08374540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868583 [patent_doc_number] => 05763224 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Decay accelerating factor (DAF) and nucleic acids encoding it' [patent_app_type] => 1 [patent_app_number] => 8/358283 [patent_app_country] => US [patent_app_date] => 1994-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 14105 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763224.pdf [firstpage_image] =>[orig_patent_app_number] => 358283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874074 [patent_doc_number] => 05763578 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'All-trans retinaldehyde binding protein, and antibodies thereto' [patent_app_type] => 1 [patent_app_number] => 8/358171 [patent_app_country] => US [patent_app_date] => 1994-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 18111 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763578.pdf [firstpage_image] =>[orig_patent_app_number] => 358171 [rel_patent_id] =>[rel_patent_doc_number] =>)